Investing

Golconda Gold Announces Appointment of New General Manager for the Summit Mine

January 15, 2026
Investing

Boundiali Gold Project produces more good drilling results

January 15, 2026
Investing

Lead Price Forecast: Top Trends for Lead in 2026

January 15, 2026
Investing

Mario Innecco: Gold, Silver Breakout — What Record Prices Really Mean

January 15, 2026
Investing

Crypto Market Update: US Senate Sets January Clock on Crypto Structure Bill

January 15, 2026
Politics

Iran allegedly airs 97 ‘coercive confessions’ amid record-breaking North Korea-style internet blackout

January 15, 2026
Home Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202
Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin
RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

You may also like

Market Presentation

June 18, 2025

Zinc Stocks: 4 Biggest Canadian Companies in 2025

August 14, 2025

Gold Price Breaches US$4,000, Silver Tests US$50

October 9, 2025

Editor’s Picks: Trump to Lift Minnesota Mining Ban,...

June 14, 2025

Spartan Metals Terminates Investor Relations Agreement

December 13, 2025

Barrick’s Plan to Sell Hemlo Mine for US$1.09...

September 15, 2025

West High YieldResources Ltd. Announces Exercise of Warrants

November 1, 2025

Rio Silver Receives Conditional Approval for $2.2M Private...

October 29, 2025

Tudor to Acquire American Creek in Latest Gold...

June 27, 2025

Investment Protection Agreement with the Ecuador Government on...

May 28, 2025